// App-Quantinova.ai

6.4 1844 : Building confidence in the basophil activation test: Standardization and external quality assurance ‐ an EAACI task force

Researchers

Presenter

  • Pascal M

Principal Investigators

  • Nopp A

  • Mayorga C

  • Edelman S

  • Santos A

  • Ebo D

  • Knol E

  • Mbs C

  • Shamji MH

  • Patil SU

  • Geilenkeuser W

  • Eberlein B

  • Hoffmann H. J

Medical Centers

  • Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

  • Karolinska Institutet, Stockholm, Sweden

  • Hospital Regional Universitario de Malaga, Malaga, Spain

  • Helsinki University Hospital, Helsinki, Finland

  • Kings College London, London, United Kingdom

  • University Institution Antwerp, Antwerp, Belgium

  • University Utrecht, Utrecht, Netherlands

  • University of Hamburg, Hamburg, Germany

  • Imperial College, London, United Kingdom

  • Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, United States

  • ReferenzInstitut für Bioinformatik, Bonn, Germany

  • Technische Universitat Munchen, Munich, Germany

  • Aarhus University Hospital, Aarhus, Denmark

Locations

  • Spain

  • Sweden

  • Finland

  • United Kingdom

  • Belgium

  • Netherlands

  • Germany

  • United States

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A